10 ML cladribine 1 MG/ML Injection — RxCUI 240754
RxNorm drug concept · Semantic clinical drug
RxCUI 240754
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI240754
Official name10 ML cladribine 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascladribine 10 MG per 10 ML Injection; cladribine 10 MG in 10 ML Injection
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)151 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cladribine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It's actually both, depending on the form. The oral tablets (brand name Mavenclad) are approved to treat relapsing forms of multiple sclerosis in adults — specifically for people w...
- What exactly is cladribine used for — is it a chemotherapy or an MS drug?
- Not exactly like a daily pill. The oral tablets are taken in a structured course — two yearly treatment courses, and each course is split into two short cycles of daily dosing. So...
- How do I actually take the MS tablets — do I take them every day?
🕸️ Concept Web — How 10 ML cladribine 1 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
10 ML cladribine 1 MG/ML Injection
RxCUI 240754 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Cladribine
44157IN
-
Cladribine
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cladribine Injection
1731084SCDF -
Cladribine Injectable Product
1152759SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Cladribine Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cladribine 1 MG/ML
315692SCDC
-
Cladribine 1 MG/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cladribine 1 MG/ML
SCDC · 315692 -
Cladribine Injection
SCDF · 1731084 -
Cladribine Injectable Product
SCDG · 1152759
📦 FDA Products & Package NDCs
4 products · 4 package NDCs
4 package NDCs map to RxCUI 240754 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9871-01 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9871-01) / 10 mL in 1 VIAL | Cladribine | Hikma Pharmaceuticals USA Inc. | 2000-02-28 |
| 42658-0010-01 | 1 mL in 1 VIAL, SINGLE-DOSE (42658-010-01) | Cladribine | Hisun Pharmaceuticals USA, Inc. | 2020-05-18 |
| 42658-0010-91 | 1 mL in 1 VIAL, SINGLE-DOSE (42658-010-91) | Cladribine | Hisun Pharmaceuticals USA, Inc. | 2023-02-28 |
| 63323-0140-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-140-10) / 10 mL in 1... | Cladribine | Fresenius Kabi USA, LLC | 2004-12-01 |
Observed labelers:
Hisun Pharmaceuticals USA, Inc. (2) ·
Fresenius Kabi USA, LLC (1) ·
Hikma Pharmaceuticals USA Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9065 | Inj cladribine per 1 mg | 4 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.